NCT05864820

Brief Summary

This observational study evaluates the goodness of the IGOODI photogrammetric scan system in measuring anthropometry and estimating the body composition of 75 healthy subjects, comparing the results with the measurements taken using methods used in clinical practice, including body circumferences and bioimpedance analysis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 18, 2023

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

May 9, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 18, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 27, 2024

Completed
Last Updated

December 10, 2024

Status Verified

December 1, 2024

Enrollment Period

1.2 years

First QC Date

May 9, 2023

Last Update Submit

December 5, 2024

Conditions

AnthropometryMusculoskeletal System

Outcome Measures

Primary Outcomes (1)

  • Correlation between anthropometric circumferences

    Association between the circumferences taken with clinical practice methodology (inelastic and flexible tape measure) and the results from the photogrammetric technology

    Baseline and after 1 year

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects of the general population

You may qualify if:

  • Male or female gender
  • Between the ages of 18 and 85
  • Caucasian race
  • Cognitively intact
  • Acceptance and signing of informed consent
  • Height between 120 and 200 cm (included)

You may not qualify if:

  • Congenital or acquired musculoskeletal deformities of the limbs or trunk
  • Implants resulting from cosmetic surgery
  • Articular prostheses and/or means of synthesis
  • Current oncological or metabolic pathologies
  • Photosensitivity
  • Epilepsy
  • Claustrophobia
  • Subjects unable to independently maintain an upright position
  • Wearers of pacemakers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Istituto Ortopedico Galeazzi

Milan, Milan, Italy

Location

Study Officials

  • Matteo Briguglio

    IRCCS Istituto Ortopedico Galeazzi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2023

First Posted

May 18, 2023

Study Start

April 18, 2023

Primary Completion

June 27, 2024

Study Completion

June 27, 2024

Last Updated

December 10, 2024

Record last verified: 2024-12

Locations

IT(1)